Photoswitch drug shows early signs of restoring light sensitivity in severely damaged retinas in first human trial
Researchers at Adelaide University have conducted the first human trial of a photoswitch drug aimed at restoring light sensitivity in severely damaged retinas. Early results show promise for treatment of a leading cause of blindness in working-age adults.
photoswitch drug retina treatment clinical trial blindness research Adelaide University
Linked Entities
Contributing Articles
Australian researchers make breakthrough in MND fight
The Sydney Morning Herald —
Low-cost treatment for multiple sclerosis shown to be as effective as standard therapy
Medical Xpress —
TROP2 marks relapse-driving colorectal cancer cells and opens path to targeted treatment
Medical Xpress —
‘Life-saving’ drug for people with opioid dependency to be pulled from Australia by end of year
The Guardian —
Photoswitch drug shows early signs of restoring light sensitivity in severely damaged retinas in first human trial
Medical Xpress —